KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Total Liabilities: 2018-2025

Historic Total Liabilities for Aurinia Pharmaceuticals (AUPH) over the last 8 years, with Sep 2025 value amounting to $161.8 million.

  • Aurinia Pharmaceuticals' Total Liabilities rose 0.25% to $161.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $161.8 million, marking a year-over-year increase of 0.25%. This contributed to the annual value of $173.2 million for FY2024, which is 1.80% up from last year.
  • According to the latest figures from Q3 2025, Aurinia Pharmaceuticals' Total Liabilities is $161.8 million, which was down 3.29% from $167.3 million recorded in Q2 2025.
  • Aurinia Pharmaceuticals' Total Liabilities' 5-year high stood at $173.2 million during Q4 2024, with a 5-year trough of $46.9 million in Q1 2021.
  • Its 3-year average for Total Liabilities is $153.2 million, with a median of $161.4 million in 2024.
  • In the last 5 years, Aurinia Pharmaceuticals' Total Liabilities declined by 9.14% in 2021 and then surged by 168.26% in 2023.
  • Quarterly analysis of 5 years shows Aurinia Pharmaceuticals' Total Liabilities stood at $64.3 million in 2021, then rose by 1.79% to $65.4 million in 2022, then soared by 160.00% to $170.1 million in 2023, then increased by 1.80% to $173.2 million in 2024, then grew by 0.25% to $161.8 million in 2025.
  • Its Total Liabilities was $161.8 million in Q3 2025, compared to $167.3 million in Q2 2025 and $154.7 million in Q1 2025.